Loading...
A randomised phase II trial of carboplatin and gemcitabine +/- vandetanib in first line treatment of advanced urothelial cell cancer patients not suitable to receive cisplatin
Jones, R Crabb, S Chester, J Elliott, Tony Huddart, R Birtle, A Evans, L Lester, J Jagdev, S Casbard, A
Jones, R
Crabb, S
Chester, J
Elliott, Tony
Huddart, R
Birtle, A
Evans, L
Lester, J
Jagdev, S
Casbard, A
Citations
Altmetric:
Abstract
Description
Date
2020
Publisher
Collections
Files
Loading...
Open Access
Adobe PDF, 310.91 KB
Keywords
Type
Article
Citation
Jones R, Crabb S, Chester J, Elliott T, Huddart R, Birtle A, et al. A randomised Phase II trial of carboplatin and gemcitabine +/- vandetanib in first-line treatment of patients with advanced urothelial cell cancer not suitable to receive cisplatin. BJU Int. 2020.